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Autoimmune diseases (ADs) are chronic conditions initiated
by the loss of immunological tolerance to self-antigens and
represent a heterogeneous group of disorders that aﬄict spe-
ciﬁctargetorgansormultiple organsystems[1].Thechronic
natureofthesediseasesplacesasigniﬁcantburdenontheuti-
lization of medical care, direct and indirect economic costs,
and quality of life. The fact that ADs share several clinical
signs and symptoms (i.e., subphenotypes), physiopatho-
logical mechanisms, and genetic factors has been called
autoimmunetautologyandindicatesthattheyhavecommon
mechanisms [2–8].
In clinical practice, there are two conditions supporting
this theory: polyautoimmunity and familial autoimmunity.
Polyautoimmunity is the presence of two or more ADs in
a single patient while familial autoimmunity occurs when
diﬀerent relatives from a nuclear family present with diverse
ADs [4]. These conditions indicate that similar genetic,
epigenetic, and environmental factors inﬂuence ADs [8].
In rhetoric, tautology (from Greek tauto, “the same” and
logos,“word/idea”)isanobviousstatement.Inmedicalprac-
tice, Sj¨ ogren’s syndrome could be considered the “autoim-
mune diabetes” or the “celiac disease” of the salivary and
lachrymal glands. In logic, tautology is a formula, which is
trueineverypossibleinterpretation.Thus,autoimmunetau-
tology means that an AD is similar to a second one, to a third
one, and so on. Its formula is Vpq = AD1   AD2   AD3,
where Vpq represents the symbol of tautology. ADs cannot
be all identical because the target cell and the aﬀected organ
may diﬀer from one AD to another one. In addition, trigger
factors as well as the age at onset may vary among them and
from one patient to another. Yet, autoimmune mechanisms
of injury may be common including predisposing and pro-
tective factors. One step forward to the demonstration of this
logically valid formula will be a new taxonomy of ADs based
on common and speciﬁc subphenotypes that will allow us
to predict and prevent them, tailor individual medical deci-
sions, and provide personalized healthcare while facilitating
patient’s participation in their treatment and eventual cure
of their disease.
In Table 1, ten shared characteristics supporting the
autoimmune tautology are summarized. In this special issue
of Autoimmune Diseases, ad o z e no fp a p e r sa r ed e v o t e dt o
these characteristics. Evolution and genetics of ADs, includ-
ing the biological signiﬁcance of evolution in autoimmune
phenomena, a meta-analysis of HLA class II in six ADs
in Latin America, genetic factors of autoimmune thyroid
diseases in Japanese, and an in silico approach of the
autoimmune tautology are included. An updated review on
epigenetics and ADs is also presented.
Environmental factors play an important role in the
induction of ADs. This special issue also contains a very
interesting hypothesis about local cartilage trauma as a
pathogenic trigger factor of autoimmunity, a review about
the induction of autoimmunity by microbial infections, and
anotheroneontheeﬀectofseleniumonHLA-DRexpression
of thyrocytes. How does age at onset inﬂuence the outcome2 Autoimmune Diseases
Table 1: Shared characteristics among autoimmune diseases (ADs) supporting the autoimmune tautology∗.
Characteristic Comment
Female predominance The more frequent the AD and the later it appears, the more women are aﬀected.
Similar pathophysiology
Damage induced by T or B cells, or both, plays a major pathogenic role in ADs. Although
the autoimmune phenotype varies depending on the target cell and the aﬀected organ, the
local mechanisms for tissue injury are similar.
Shared subphenotypes
Mathematical approaches for precisely deﬁning subphenotypes based on accurate clinical
and immunological databases, combined with strengthening molecular genetics analyses,
have signiﬁcant promise for a better understanding of ADs.
Age at onset inﬂuences severity Early age at onset is a poor prognostic factor for some ADs.
Similar environmental factors
Although a latitudinal gradient of infectious agents exists, Epstein-Barr virus and
cytomegalovirus are notorious as they are consistently associated with multiple ADs. Some
infections could be protective against ADs development. Smoking has also been
consistently associated with several ADs.
Ancestry inﬂuences clinical presentation Amerindian ancestry inﬂuences the risk of acquiring ADs as well as its severity.
Common genetic factors
The genetic risk factors for ADs consist of two forms: those common to many ADs and
those speciﬁc to a given disorder. Combinations of common and disease-speciﬁc alleles at
HLA and non-HLA genes in interaction with epigenetic and environmental factors over
time will determine the ﬁnal phenotype.
Polyautoimmunity Factors signiﬁcantly associated with polyautoimmunity are female gender and familial
autoimmunity.
Familial autoimmunity
Unlike familial AD, which corresponds to the presence of one speciﬁc AD in various
members of a nuclear family, familial autoimmunity uses the term “autoimmune disease”
as a trait that encompasses all accepted pathologies for which evidence suggests an
autoimmune origin.
Similar treatment Similar biological and nonbiological therapies are used to treat diverse ADs.
∗Adapted from references [2–8].
of ADs is also reviewed, and an update on lupus nephritis is
oﬀered.
Last but not least, a careful analysis of concomitant ADs
in patients with systemic lupus erythematosus, rheumatoid
arthritis (RA), multiple sclerosis (MS), and systemic sclerosis
is reported. Polyautoimmunity is the term proposed for this
association of disorders, which encompasses the concept of
a common origin for these diseases. A lack of association
betweenspondyloarthropathies(SpAs)andADsisdescribed,
highlighting the fact that SpAs correspond more to autoin-
ﬂammatory diseases rather than to ADs.
We hope that readers of Autoimmune Diseases willﬁndin
this special issue not only accurate data and updated reviews
on the common mechanisms of ADs, but also important
questions to be resolved such as their missing heritability,
the antagonisms of some disorders (i.e., RA and MS), their
prevention, the eﬀect of ethnicity, socioeconomic status and
health care system on their outcome, and the role of the
autoimmunologist, among others.
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